Copenhagen, Denmark

Peter Thygesen

This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Novo Nordisk A/s, Novo Nordisk Healthcare Ag. Active years: 2008-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Thygesen. Retrieved from https://idiyas.com/inventor/peter-thygesen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3


Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Sure, let's start drafting the article about inventor Peter Thygesen:

Title: Investigating Innovator Peter Thygesen's Contributions to Growth Hormone Compounds

Introduction: Peter Thygesen, a male inventor hailing from Copenhagen, Denmark, has made significant strides in the field of growth hormone compounds. With a total of 3 patents under his belt, Thygesen is known for his groundbreaking work in creating stable growth hormone compounds resistant to proteolytic degradation.

Latest Patents: Thygesen's latest patents revolve around stable growth hormone compounds resistant to proteolytic degradation. The compounds feature additional disulphide bridges and single point mutations, enhancing their resilience against proteolytic degradation. This innovation marks a significant advancement in the field of growth hormone research.

Career Highlights: In his illustrious career, Thygesen has collaborated with reputable companies such as Novo Nordisk A/S and Novo Nordisk Healthcare AG. These collaborations have helped Thygesen bring his innovative ideas to fruition, making valuable contributions to the field of biotechnology.

Collaborations: Throughout his career, Thygesen has worked closely with esteemed colleagues such as Helle Demuth and Lars Thim. Their collaborative efforts have led to the successful development of novel growth hormone compounds, showcasing Thygesen's prowess as a visionary inventor.

Conclusion: Peter Thygesen's dedication to advancing growth hormone compounds has solidified his reputation as a pioneering inventor in the pharmaceutical industry. His innovative approach to creating stable compounds resistant to proteolytic degradation has paved the way for future advancements in biotechnology, making him a standout figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…